Texas Governor Greg Abbott recently signed House Bill 1535 expanding the list of conditions eligible for treatment with medical cannabis in the form of low-THC cannabis (or CBD). The bill falls under the Compassionate Use Program which will now provide access to medical cannabis for patients suffering from seizure disorders, multiple sclerosis, spasticity, amyotrophic lateral
Read MoreDr. Karen Keough
“In Our Arms” Provides Much Needed Online Support for Families Facing Complex Diagnoses
Child Neurology Consultants cherish the opportunity to keep in touch with patients and their families even long after their care has ended with us. Like Juli Henderson. She is the parent of a very special former patient (her son Robert) of Dr. Karen Keough’s and the founder of an important new online community dedicated to
Read MoreChild Neurology Consultants’ Physicians Named ‘Top Docs for Kids’ in Austin
Once again, many of our physicians were recognized for their outstanding work and patient care. Austin Monthly magazine recently named its “Top Docs for Kids” in the April issue, with ten of our CNCA physicians making the list. We’re not surprised — we know kids. It’s our specialty. We are passionate about meeting them, treating
Read MoreHow Effective is Laser Therapy for Seizures?
There are many ways we treat epilepsy and seizures at Child Neurology Consultants of Austin. Traditional seizure medications, dispensary CBD oil, electrical stimulation through the vagus nerve, and ultimately brain surgery (if seizures continue despite these treatments) are all potential options. MRI-guided laser therapy is a form of minimally invasive surgery using a proven technology
Read MoreWe’re Ushering In 2021 With A Slew of ‘Top Doctors’
Child Neurology Consultants of Austin is proud to start off the year with a special honor. Several of our physicians have been named to Austin Monthly’s annual listing of “Top Doctors.” Our practice is grateful to have so many regularly recognized by our peers across the local Austin community, and especially this year when everyone
Read MoreKilometers 4 Carter
Kilometers 4 Carter is a cause close to our hearts at Child Neurology Consultants of Austin. The inspiration for the cause is Carter Halliburton, a young patient of pediatric neurologist, Dr. Karen Keough, who suffers from a rare, debilitating neurological condition known as SynGAP1. This weekend on June 13, Carter’s father Peter Halliburton will be
Read MoreDr. Karen Keough Heads to Disneyland As Featured Speaker for Epilepsy Expo
Dr. Karen Keough will soon be packing up her mouse ears and heading off to Disneyland to participate in the annual Epilepsy Awareness & Education Expo /Epilepsy Awareness Day, November 4 – 6, taking place at the Southern California theme park. While there, Dr. Keough will join a panel titled “CBD in Epilepsy”, sharing updates
Read MoreDr. Karen Keough Revisits Kenya
Stunning scenery, majestic wildlife, and eternally-grateful patients—it never gets tiring. Dr. Karen Keough, board-certified child neurologist and neurophysiologist with Child Neurology Consultants of Austin, recently returned from her fifth trip to Kenya with HEAL Kenya and Ubuntu Life. For the second time, her son, Seth Richards, a Social Worker, went along to help with the
Read MoreOn FOX7 Austin: Dr. Karen Keough Shares About Young Patient’s Epilepsy Non-Profit
Weeks ago, we shared a story about one of Dr. Karen Keough’s young epilepsy patients who, at just 11-years old, launched a non-profit to raise more awareness about his disease. The non-profit is called Chase for the Cure, named after young Chase Johnson. FOX7 Austin was similarly inspired by the ambitious pre-teen. They interviewed Chase, his family
Read More10-Year Old Creates Non-Profit to Raise Awareness About His Own Condition
Seven months ago, ten-year-old Chase Johnson came to his father frustrated that his school’s disease awareness programs mostly focused on cancer and diabetes. “What about epilepsy?” he said. Epilepsy is a neurological condition that affects the nervous system often triggering seizures in patients and affects more than two million people in the U.S. Chase was
Read More